The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: post hoc analysis of an Austrian multicenter, noninterventional study
AST/ALT(De Ritis)比值可预测接受一线白蛋白结合型紫杉醇和吉西他滨治疗的胰腺癌患者的临床结局:一项奥地利多中心非干预性研究的事后分析
期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/1758835919900872
Riedl, Jakob Michael; Posch, Florian; Prager, Gerald; Eisterer, Wolfgang; Oehler, Leopold; Sliwa, Thamer; Wilthoner, Klaus; Petzer, Andreas; Pichler, Petra; Hubmann, Eva; Winder, Thomas; Burgstaller, Sonja; Korger, Markus; Andel, Johannes; Greil, Richard; Neumann, Hans-Joerg; Pecherstorfer, Martin; Philipp-Abbrederis, Kathrin; Djanani, Angela; Gruenberger, Birgit; Laengle, Friedrich; Wöll, Ewald; Gerger, Armin